Medico Remedies Limited (MEDICO) — Cash Flow Quality Index
Medico Remedies Limited (MEDICO) has a Cash Flow Quality Index of 0.15x as of September 2025. Operating cash flow of Rs6.43 Million is below net income of Rs43.86 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Medico Remedies Limited (MEDICO) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medico Remedies Limited Cash Flow Quality Index (2013–2026)
Historical Cash Flow Quality Index for Medico Remedies Limited across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MEDICO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Medico Remedies Limited (2013–2026)
Year-by-year earnings quality comparison for Medico Remedies Limited. For live market cap and the full company financial profile, see Medico Remedies Limited market capitalisation.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2026 | 0.08x | Rs10.06 Million | Rs131.15 Million | ▼ -84.2% |
| 2025 | 0.48x | Rs48.92 Million | Rs100.93 Million | ▲ +64.8% |
| 2024 | 0.29x | Rs24.38 Million | Rs82.91 Million | ▼ -73.9% |
| 2023 | 1.13x | Rs81.67 Million | Rs72.42 Million | ▼ -5.9% |
| 2022 | 1.20x | Rs58.62 Million | Rs48.90 Million | ▲ +127.5% |
| 2021 | -4.36x | Rs-113.10 Million | Rs25.92 Million | ▼ -835.5% |
| 2020 | 0.59x | Rs9.67 Million | Rs16.30 Million | ▼ -73.8% |
| 2019 | 2.26x | Rs49.24 Million | Rs21.75 Million | ▼ -16.8% |
| 2018 | 2.72x | Rs50.97 Million | Rs18.73 Million | ▲ +250.5% |
| 2017 | -1.81x | Rs-30.52 Million | Rs16.88 Million | ▲ +9.3% |
| 2016 | -1.99x | Rs-37.29 Million | Rs18.71 Million | ▼ -588.7% |
| 2015 | -0.29x | Rs-3.19 Million | Rs11.01 Million | ▼ -110.2% |
| 2014 | 2.85x | Rs27.27 Million | Rs9.58 Million | ▼ -2.3% |
| 2013 | 2.91x | Rs20.57 Million | Rs7.06 Million | — |